Authors: Tomassa-Irriguible TM, Lielsa-Berrocal L

PMID: 34243781 PMCID: PMC8269403 DOI: 10.1186/s12937-021-00727-z


There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.

Keywords: ARDS; COVID-19; Critically ill patient; Epidemiology; ICU; SARS-CoV-2; Vitamin C.

More on: MATH+

More on: COVID-19 | Vitamin C